• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
[Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:477-502.
2
[Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].[胰腺在降血糖磺酰胺类药物作用模式中的核心作用的生理和药理学方面]
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:216-55.
3
[Mode of action of blood glucose lowering sulfonamides. Other extrapancreatic effects].[降血糖磺酰胺类药物的作用机制。其他胰腺外效应]
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:415-28.
4
[Hypoglycemic sulfonamides].
Actual Pharmacol (Paris). 1968;21:173-90.
5
[Normal histology of the beta-cells during insulin secretion].
Acta Diabetol Lat. 1968 Oct;5 Suppl 1:417-35.
6
[Current views on the mode of action of hypoglycemic sulfonamides].
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:201-15.
7
[Ultrastructural events associated with the action of tolbutamide and glybenclamide on pancreatic B-cells in vivo and in vitro].[甲苯磺丁脲和格列本脲在体内和体外对胰腺β细胞作用相关的超微结构变化]
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:271-374.
8
[Regulation of insulin release in perifused pancreatic tissue].[灌注外周胰腺组织中胰岛素释放的调节]
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:580-96.
9
[The action of sulfonylureas on the insulin secretion of the perfused rat pancreas].[磺脲类药物对灌注大鼠胰腺胰岛素分泌的作用]
Acta Diabetol Lat. 1969 Sep;6 Suppl 1:256-70.
10
[The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].[各种磺酰脲衍生物对健康受试者、肥胖者及成年型糖尿病患者口服葡萄糖耐量试验的影响（作者译）]
Dtsch Med Wochenschr. 1974 Mar 1;99(9):385-8. doi: 10.1055/s-0028-1107768.

引用本文的文献

1
Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.糖尿病患者在使用新型磺脲类化合物Ro 6-4563治疗前后的葡萄糖耐量、血浆胰岛素和血脂情况。
Eur J Clin Pharmacol. 1971 Dec;4(1):22-8. doi: 10.1007/BF00568894.
2
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide. II. Repeated administration in combination with glucose.甲苯磺丁脲、格列本脲、格列波脲和格列齐特的药效学方面。II. 与葡萄糖联合重复给药。
Diabetologia. 1971 Dec;7(6):455-60. doi: 10.1007/BF01212062.
3
Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects.
甲苯磺丁脲、格列本脲、格列波脲和格列齐特的药效学方面。I. 糖尿病患者的剂量反应关系及重复给药
Diabetologia. 1971 Dec;7(6):449-54. doi: 10.1007/BF01212061.
4
[Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].[第一代和第二代降糖磺酰胺类药物使用的最新研究发现]
Klin Wochenschr. 1973 Jan 15;51(2):68-77. doi: 10.1007/BF01467758.
5
Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.通过静脉注射格列本脲-葡萄糖反应联合试验对既往胰岛素依赖型糖尿病患者进行口服抗糖尿病治疗的控制性扩展。
Diabetologia. 1972 Feb;8(1):41-7. doi: 10.1007/BF01219985.
6
The management of diabetes mellitus in older individuals.老年糖尿病的管理
Drugs. 1991 Apr;41(4):548-65. doi: 10.2165/00003495-199141040-00004.

[Current pathophysiological and clinical aspects of the mode of action of blood glucose lowering sulfonamides].

作者信息

Pfeiffer E F

出版信息

Acta Diabetol Lat. 1969 Sep;6 Suppl 1:477-502.

PMID:4906024
Abstract
摘要